1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- manufacturers
|
| | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- Basic information |
| Product Name: | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- | | Synonyms: | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)-;(3S,4R)-3-Ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide;Upadacitinib Impurity 109;Upatinib Impurity 109;RMA-788;(3S,4R)-3-Ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | | CAS: | 2411540-30-0 | | MF: | C24H25F3N6O3S | | MW: | 534.55 | | EINECS: | | | Product Categories: | | | Mol File: | 2411540-30-0.mol | ![1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- Structure](CAS/20210305/GIF/2411540-30-0.gif) |
| | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- Chemical Properties |
| density | 1.51±0.1 g/cm3(Predicted) | | pka | 11.84±0.60(Predicted) |
| | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- Usage And Synthesis |
| | 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)- Preparation Products And Raw materials |
|